title: Psychotropic adjuvant analgesics for pain in cancer and AIDS.
abstract: The 'WHO Analgesic Ladder' is a well validated approach for the selection of appropriate analgesic therapy for cancer pain as well as pain in AIDS. The mainstay of analgesic intervention for cancer and AIDS pain of moderate to severe intensity continues to be the appropriate use of opioid analgesics. There is, however, a growing appreciation for the role of adjuvant analgesics, such as antidepressants and other psychotropic medications, at each step of the WHO Analgesic Ladder, particularly in the treatment of neuropathic pain. Knowledge of the indications and usefulness of psychotropic analgesic drugs in cancer and AIDS pain populations will be most important to clinicians practicing in psycho-oncology/AIDS settings, particularly since these drugs are useful not only in the treatment of psychiatric complications of cancer and AIDS, but also as adjuvant analgesic agents in the management of pain. This paper reviews the literature on the use of antidepressants, psychostimulants, neuroleptics, anticonvulsants and other psychotropic analgesics in the management of cancer and AIDS pain. Mechanisms of analgesia, drug selection, and recommendations for clinical usage are discussed. The appropriate and timely use of psychotropic adjuvant analgesic drugs represents an opportunity for active psychiatric contribution to the multidisciplinary management of cancer and AIDS pain.
authors.affiliation: Department of Psychiatry and Behavioral Sciences, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. breitbaw@mskcc.org
authors.forename: W
authors.initials: W
authors.lastname: Breitbart
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000503:physiopathology* / Q000523:psychology; D000277:Adjuvants, Pharmaceutic / Q000627:therapeutic use; D000700:Analgesics / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006801:Humans; D009369:Neoplasms / Q000503:physiopathology* / Q000523:psychology; D010146:Pain / Q000188:drug therapy* / Q000209:etiology; D011619:Psychotropic Drugs / Q000627:therapeutic use*
chemical_list: D000277:Adjuvants, Pharmaceutic; D000700:Analgesics; D011619:Psychotropic Drugs